November 5, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Lewis H. Bender, Founder & CEO, Intensity Therapeutics
In this Q&A, Bender discusses the insight behind Intensity's approach, what sets its delivery platform apart, lessons he's learned leading a biotech company through an IPO and late-stage trials, and changes needed to get more effective, less toxic treatments to patients faster. More

Press Releases

  • Ascentage Pharma: Will Present Data From Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026 More
  • GeneDx and Mirum Pharmaceuticals: Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing More

Financial News


  • Cartesian Therapeutics: Third Quarter 2026 Financial Results and Business Update More
  • Emergent BioSolutions: Receives $22.3 Million Delivery Order Modification to Supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War More
  • November 6, 2026: BioPharmCatalyst Weekly Watchlist: Key Phase 3 Catalysts Left for the Quarter More
  • Precigen: Third Quarter 2026 Results Highlighted by Strong Sequential PAPZIMEOS Revenue Growth and Positive Cash Flow Ahead of Guidance More
  • QIAGEN: Full Q3 2026 Results More
  • Quoin Pharmaceuticals: Corporate Update and Third Quarter 2026 Financial Results More
  • United Therapeutics: Buydown of Ralinepag Royalty More
  • United Therapeutics: Third Quarter 2026 Financial Results More
Cardinal Health Logo
Turn unstructured bladder cancer data into actionable real-world insights.
Download the case study to learn how.

Media/Misc Coverage

  • Big4Bio CEO Weekly Q&A: Lewis H. Bender, Founder & CEO, Intensity Therapeutics More
  • Biotech & Pharma Updates | November 4, 2026 More
  • SciLnq: Therapeutic Antibody Development Consulting More
  • Subscribe to LifeSci Startup for Updates on US Startups More
  • Vanda Drives Straight Into FDA Trouble With Fast-Paced Nereus Ad More

Career Moves

Slone Partners Places Farhad Ghavami as Chief Executive Officer at SeqCenter
Learn More  →
  • CollectiveMinds: The Boardroom Is Changing. Is Your Experience Visible? More
  • Fierce Biotech Layoff Tracker 2026: Ultragenyx Lays Off 20%; Molecular Partners Trims 44% More
  • 1 in 5 Have Had Multiple Biopharma Layoffs, Poll Finds More
  • OPPORTUNITY: Director of Compliance, Remote More
  • OPPORTUNITY: Head of Market Development & Strategy, California More
  • OPPORTUNITY: Senior Vice President, Regulatory Affairs & Quality Assurance, Boston More
  • Slone Partners: Doing More With Less - Building the Right Nonprofit Leadership Team in a Resource-Constrained Environment More
  • Slone Partners: Leading Through AI - The New Playbook for Healthtech Executives More
On Your Mark 2027 | Every event of JPM Week. Jnauary 11-14, San Francisco. List your event - free. onyourmark.bio

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: Biotech Showcase, Jan 11-13
Learn More  →
  • Scaling Academic Research Programs Through Strategic Colony Management Partnerships Nov 11
  • 23rd Annual Pantheon Awards Nov 12
  • 2026 LSPA Patient Summit Nov 12
  • Patient Pathways (Use code 26B4B10 for 10% off) Nov 17-20
  • Pricing & Contracting WEST (Use code 26B4B10 for 10% off) Dec 7-8
  • Trade and Channel Strategies (Use code 26B4B10 for 10% off) Dec 8-10
  • Advancing Drug Development Forum Dec 10

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: Capital Region Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

Capital Region Sponsors


Follow us


Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:Capital Region, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.